NCT02308475

Brief Summary

To assess the ability of a novel 3rd generation dual-source CT system to demonstrate myocardial perfusion in a cohort of patients presenting to the Chest Pain Center with acute chest pain.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2014

Completed
10 days until next milestone

Study Start

First participant enrolled

December 1, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 4, 2014

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 6, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 6, 2015

Completed
3 years until next milestone

Results Posted

Study results publicly available

July 6, 2018

Completed
Last Updated

July 6, 2018

Status Verified

June 1, 2018

Enrollment Period

7 months

First QC Date

November 21, 2014

Results QC Date

April 30, 2018

Last Update Submit

June 4, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic Accuracy of Dynamic Perfusion CT

    The diagnostic accuracy of dynamic perfusion CT of the heart for evaluation of perfusion, viability and function during stress and rest will be compared with SPECT myocardial perfusion imaging using p-values for comparison of reader specific values, calculated by means of the McNemar test.

    1 Day

Secondary Outcomes (2)

  • CTMP/SPECT MPI Disagreement

    1 Day

  • Radiation Dose

    1 Day

Study Arms (1)

Myocardial Stress CT Perfusion

EXPERIMENTAL

Dynamic volume CT myocardial perfusion using the experimental scanner (Force, Siemens), applying the "dynamic shuttle" mode will be used to rapidly cover the entire cardiac anatomy during infusion of a contrast medium bolus for monitoring bolus passage through the left ventricular myocardium.

Device: Somatom Force CT Scanner

Interventions

Dynamic CT perfusion of the heart

Myocardial Stress CT Perfusion

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject must present with symptoms of acute but atypical or recurrent chest pain.
  • Subject must have been referred for cardiac CT angiography OR subject must have undergone clinically indicated SPECT with positive or equivocal findings OR subject must have undergone clinically indicated SPECT with prior cardiac CT angiography that showed moderate or severe stenosis.
  • Subject must be 18-85 years of age.
  • Subject must provide written informed consent prior to any study-related procedures being conducted.
  • Subject must be willing to comply with all clinical study procedures.

You may not qualify if:

  • Subject is a pregnant or nursing female.
  • Subject has severe asthma or COPD requiring frequent inhaler use.
  • Subject has prior diagnosis of obstructive CAD that has not been revascularized.
  • Subject with implanted rhythm devices (pacemaker, defibrillator).
  • Subject has significant arrhythmia.
  • Subject has high grade heart block.
  • Subject has resting heart rate \< 45 bpm, systolic blood pressure \<90 mm Hg, or has consumed caffeine within the last 12 hours.
  • Subject has an acute psychiatric disorder.
  • Subject is unwilling to comply with the requirements of the protocol.
  • Subject has previously entered this study.
  • Subject has an allergy against iodinated contrast or pharmaceutical stressors used in this study.
  • Subject suffers from claustrophobia.
  • Subject has impaired renal function (creatinine \> 1.5 mg/dl).
  • Subject is in unstable condition.
  • ST-elevations, new transient ST changes greater than 0.05mV or T-wave inversions with symptoms.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

MeSH Terms

Conditions

Chest Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Brian Jacobs - Program Assistant
Organization
Medical University of South Carolina

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 21, 2014

First Posted

December 4, 2014

Study Start

December 1, 2014

Primary Completion

July 6, 2015

Study Completion

July 6, 2015

Last Updated

July 6, 2018

Results First Posted

July 6, 2018

Record last verified: 2018-06

Locations